IDH2 and central nervous system cancer: Moreover, a study investigated the prognostic value of IDH mutations in 99 secondary high-grade gliomas revealed that an IDH mutation did not associate with increased PFS although secondary anaplastic glioma patients with IDH mutation showed a significantly improved outcome (31).